FDA Consumer

View more issues:

Articles in Nov, 1994 issue of FDA Consumer

• Orphan drug approved to treat rare kidney disorder - Cystagon, by Mylan Pharmaceuticals Inc., may be used for nephropathic cystinosis and prevent or slow kidney damage
• New drug approval approach boosts fight against heroin addiction - includes related article on methadone maintenance program regulations
  by Dixie Farley
• Problem pasta pulled from market
  by Marian Segal
• Parlodel no longer to be sold for lactation suppression - safety concerns lead to withdrawal of drug by Sandoz Pharmaceuticals Corp
• Inactivity increases chance of stroke in older men - study results published in the American Journal of Epidemiology
• Cytokines: putting body mechanics to work
  by Marian Segal
• Device approved to unblock heart arteries - Johnson and Johnson Palmaz-Schatz Balloon-Expandable Stent
• Educating public about raw oyster problem - Vibrio vulnificus infection prevention
• The new food label: coping with diabetes - includes related information
  by Paula Kurtzweil
• Trio sentenced in Mississippi illegal oyster distribution
  by John Henkel
• Drug prevents mother-fetus HIV transmission - Retrovir, or zidovudine, approved for use in pregnant women with HIV virus
• Women and heart disease - Cover Story
  by Margie Patlak
• Veterinarians sentenced for selling illegal drugs
  by Kevin L. Ropp
• Blood test approved to detect prostate cancer - Tandem prostate specific-antigen Assay
• EMI and medical devices - electromagnetic interference
• How to avoid the flu - includes related article on flu vaccine
  by Evelyn Zamula
• Blood center closed for violations
  by Paula Kurtzweil